Swiss-based Non-profit GARDP Supports the Development of Debiopharm's New Potential ...
The Global Antibiotic Research Development Partnership (GARDP) and the Swiss-based global biopharmaceutical company Debiopharm have signed a memorandum of understanding to develop Debio 1453, a novel ...